High prevalence of KRAS and GNAS mutations in pseudomyxoma peritonei underscores opportunities for targeted therapeutic strategies

Pseudomyxoma peritonei (PMP) is a rare, slow-growing cancer with few efficacious treatment options in unresectable cases. Mutations in the KRAS and GNAS oncogenes are common, but the reported frequencies vary greatly, most likely because of low tumor cellularity in peritoneal tumor samples. With tre...

Descripció completa

Dades bibliogràfiques

Autors principals:	Torgunrud Annette, Lund-Andersen Christin, Davidson Ben, Nitschke Marcussen Ina Katrine, Larsen Stein G., Dagenborg Vegar, Flatmark Kjersti
Format:	Artigo
Idioma:	Inglês
Publicat:	De Gruyter 2025-12-01
Col·lecció:	Pleura and Peritoneum
Matèries:	pseudomyxoma peritonei kras mutation gnas mutation oncogenes targeted therapy
Accés en línia:	https://doi.org/10.1515/pp-2025-0034
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!